Oppenheimer & Co’s Intellia Therapeutics NTLA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.37M	Buy	106,924 +1,759	+2%	+$22.4K	0.02%	732
2025 Q4	$945K	Buy	105,165 +808	+0.8%	+$11.1K	0.01%	822
2025 Q3	$1.8M	Sell	104,357 -1,857	-2%	-$22.9K	0.02%	646
2025 Q2	$996K	Buy	106,214 +87,506	+468%	+$719K	0.01%	855
2025 Q1	$133K	Buy	18,708 +823	+5%	+$8.31K	﹤0.01%	1500
2024 Q4	$209K	Buy	+17,885	New	+$279K	﹤0.01%	1438
2023 Q4	–	Sell	-7,810	Closed	-$247K	–	1436
2023 Q3	$247K	Sell	7,810 -372	-5%	-$14.4K	0.01%	1199
2023 Q2	$334K	Buy	+8,182	New	+$332K	0.01%	1127
2021 Q4	–	Sell	-1,824	Closed	-$245K	–	1538
2021 Q3	$245K	Sell	1,824 -447	-20%	-$67.7K	﹤0.01%	1306
2021 Q2	$368K	Buy	+2,271	New	+$177K	0.01%	1153